Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.
The objectives of the study are to confirm safety and performance of the Zimmer® Nexel™ Total Elbow when used in primary or revision total elbow replacement by analysis of standard scoring systems, radiographs, and adverse event records.
The safety of the device will be monitored using the frequency and incidence of reporting adverse events.
The performance of the device will be evaluated by assessing the pain and functional performance, survival of the device, patient health status, and radiographic success of the implant.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Retrospective | Experimental | Patients who have had primary or revision total elbow arthroplasty using the Nexel Total Elbow, and who have surgical details available |
|
| Prospective | Experimental | Patients who are having primary or revision total elbow arthroplasty who will receive the Nexel Total Elbow |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Nexel Total Elbow | Device | Nexel Total Elbow used in primary or revision total elbow arthroplasty |
|
| Measure | Description | Time Frame |
|---|---|---|
| Survivorship | Based on removal or intended removal of the device and determined using the Kaplan-Meier method | 10 years |
Not provided
Not provided
Inclusion Criteria:
Patient is 18 years of age or older.
Patient must have signed Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent.
Patient is a candidate for primary or revision total elbow arthroplasty, based on symptoms including at least one of the following:
Patient is willing and able to complete scheduled follow-up evaluations as defined by the protocol.
Additional Retrospective Arm Inclusion Criteria
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Richard Marek | Contact | 574-453-7567 | richard.marek@zimmerbiomet.com | |
| Ryan Boylan | Contact | 574-527-7934 | ryan.boylan@zimmerbiomet.com |
| Name | Affiliation | Role |
|---|---|---|
| Hillary Overholser, MS | Zimmer Biomet | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Panorama Orthopedics and Spine Center | Recruiting | Golden | Colorado | 80401 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| OrthoCarolina Research Institute | Recruiting | Charlotte | North Carolina | 28207 | United States |
|
| Rothman Institute | Recruiting | Philadelphia | Pennsylvania | 19107 | United States |
|
| Campbell Clinic | Recruiting | Germantown | Tennessee | 38138 | United States |
|
| Sydney Shoulder & Elbow, NSW | Terminated | Sydney | New South Wales | 2067 | Australia |
| Coxa Hospital | Recruiting | Tampere | Finland |
|
| Hôpital Purpan (Centre Hospitalier Universitaire Toulouse) | Terminated | Toulouse | France |
| Arcus Sportklinik | Terminated | Pforzheim | Germany |
| AO Mauriziano | Recruiting | Torino | 10128 | Italy |
|
| Amphia Ziekenhuis Breda | Active, not recruiting | Breda | Netherlands |
| Wrightington | Recruiting | Wigan | United Kingdom |
|
| ID | Term |
|---|---|
| D000844 | Ankylosis |
| D007593 | Joint Instability |
| D010003 | Osteoarthritis |
| D001851 | Bone Diseases, Metabolic |
| ID | Term |
|---|---|
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D001168 | Arthritis |
| D012216 | Rheumatic Diseases |
| D001847 | Bone Diseases |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided